Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Adial Pharmaceuticals, Inc. (ADIL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.2400-0.0450 (-3.50%)
At close: 04:00PM EDT
1.2300 -0.01 (-0.81%)
After hours: 04:25PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.63
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 35.0800
52 Week Low 31.0400
50-Day Moving Average 31.3424
200-Day Moving Average 32.3669

Share Statistics

Avg Vol (3 month) 3216.86k
Avg Vol (10 day) 3402k
Shares Outstanding 520.95M
Implied Shares Outstanding 6N/A
Float 818.34M
% Held by Insiders 113.37%
% Held by Institutions 18.66%
Shares Short (Apr 28, 2022) 4860.31k
Short Ratio (Apr 28, 2022) 46.18
Short % of Float (Apr 28, 2022) 44.04%
Short % of Shares Outstanding (Apr 28, 2022) 43.63%
Shares Short (prior month Mar 30, 2022) 4849.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-170.58%
Return on Equity (ttm)-518.38%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -17.69M
Net Income Avi to Common (ttm)-19.42M
Diluted EPS (ttm)-1.0040
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.06M
Total Cash Per Share (mrq)0.26
Total Debt (mrq)256.96k
Total Debt/Equity (mrq)7.32
Current Ratio (mrq)2.37
Book Value Per Share (mrq)0.35

Cash Flow Statement

Operating Cash Flow (ttm)-11.95M
Levered Free Cash Flow (ttm)-5.33M
Advertisement
Advertisement